Dr. Reddy’s Laboratories has entered into a definitive agreement to acquire Betapharm Group, the fourth-largest generic pharmaceuticals company in Germany, for a total cost of $571.8 million in cash. Betapharm markets generic drugs with a focus on long-term therapy products with high prescription rates. Its current portfolio includes about 145 marketed products. Located in Augsburg, Germany, Betapharm currently employs about 370 people including a sales force of about 250. Dr Anji Red...